Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Apexigen, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +5 vs. Q4 2022
- Shares held
- 3.37M
- +201.6K (+6.4%) vs. Q4 2022
- Total value
- $1.64M
- −$516.3K (−23.9%) vs. Q4 2022
- New holders
- 7
- 3 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 17 | $1.37M |
| Q1 2023 | 20 | $1.64M |
| Q4 2022 | 15 | $2.16M |
| Q3 2022 | 17 | $8.48M |
| Q2 2022 | 1 | $912.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Apexigen, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 1,028 | $0 | 0.00% | +1,028 | New |
| Cutler Group LP | 800 | $0 | 0.00% | +800 | New |
| Wells Fargo & Company | 148 | $72 | 0.00% | +21+16.5% | Added |
| UBS Group AG | 4,376 | $2.13K | 0.00% | −5,657−56.4% | Reduced |
| Tower Research Capital LLC (TRC) | 11,758 | $6.00K | 0.00% | +1,450+14.1% | Added |
| Destination Wealth Management | 13,216 | $6.44K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 14,812 | $7.00K | 0.00% | +14,812 | New |
| Susquehanna International Group, LLP | 15,546 | $7.77K | 0.00% | +3,695+31.2% | Added |
| Millennium Management LLC | 21,771 | $11.0K | 0.00% | +21,771 | New |
| Two Sigma Securities, LLC | 28,122 | $13.7K | 0.00% | +28,122 | New |
| Two Sigma Investments, LP | 28,970 | $14.1K | 0.00% | +28,970 | New |
| Northern Trust Corp | 31,041 | $15.1K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 43,626 | $21.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 54,300 | $27.1K | 0.00% | 00.0% | Unchanged |
| CVI Holdings, LLC | 150,000 | $75.0K | 0.03% | +150,000 | New |
| Geode Capital Management, LLC | 178,760 | $89.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 213,833 | $104.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 256,935 | $125.1K | 0.00% | 00.0% | Unchanged |
| Fan Yu | 401,757 | $195.7K | 10.77% | 00.0% | Unchanged |
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $922.6K | 0.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,624−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,799−100.0% | Sold out |